"Designing Growth Strategies is in our DNA"

Insulin Pump Market Size, Share & Industry Analysis, By Product Type (Pumps [Tethered Pumps, Patch Pumps, and Others] and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI102735

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 17.2% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Product Type

  • Pumps
    • Tethered Pumps
    • Patch Pumps
    • Others
  • Consumables  

By Disease Indication

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Hospital Pharmacy
  • Retail & Online Pharmacy

By Geography

  • North America (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • U.S. (By Disease Indication)
    • Canada (By Disease Indication)
  • Europe (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • U.K. (By Disease Indication)
    • Germany (By Disease Indication)
    • France (By Disease Indication)
    • Italy (By Disease Indication)
    • Spain (By Disease Indication)
    • Scandinavia (By Disease Indication)
    • Rest of Europe (By Disease Indication)
  • Asia Pacific (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • China (By Disease Indication)
    • Japan (By Disease Indication)
    • India (By Disease Indication)
    • Australia (By Disease Indication)
    • Southeast Asia (By Disease Indication)
    • Rest of Asia Pacific (By Disease Indication)
  • Latin America (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • Brazil (By Disease Indication)
    • Mexico (By Disease Indication)
    • Rest of Latin America (By Disease Indication)
  • Middle East & Africa (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • GCC (By Disease Indication)
    • South Africa (By Disease Indication)
    • Rest of MEA (By Disease Indication)
  • 2019-2032
  • 2023
  • 2019-2022
  • 181
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann